Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice
- 31 May 1991
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (5) , 447-454
- https://doi.org/10.1016/0028-3908(91)90005-v
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Nonlinear kinetics of the thiamine cation in humans: Saturation of nonrenal clearance and tubular reabsorptionJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivoLife Sciences, 1990
- Pharmacokinetics of Galanthamine Hydrobromide after Single Subcutaneous and Oral Dosage in HumansPharmacology, 1989
- A New Criterion for Selection of Pharmacokinetic Multiexponential EquationsJournal of Pharmaceutical Sciences, 1988
- HEPATOTOXICITY OF TETRAHYDROACRIDINEThe Lancet, 1988
- Bioavailability of Oral PhysostigmineNew England Journal of Medicine, 1985
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- A Study of the Cholinesterases of the Canine Pancreatic Sphincters and the Relationship Between Reduced Butyrylcholinesterase Activity and Pancreatic Ductal HypertensionAnnals of Surgery, 1980
- THE INTERACTION OF HUMAN CHOLINESTERASES WITH ANTICHOLINESTERASES USED IN THE THERAPY OF MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1966